FDA Inspection 1093954 — Hillestad Pharmaceuticals USA, Inc.

Hillestad Pharmaceuticals USA, Inc. — FEI 2917045

The FDA completed an inspection of Hillestad Pharmaceuticals USA, Inc. on June 20, 2019 in Woodruff, WI. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Food/Cosmetics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
June 20, 2019
Fiscal Year
2019
Product Type
Food/Cosmetics
Project Area
Food Composition, Standards, Labeling and Econ
Location
Woodruff, WI (United States)

Citations

IDCFRDescription
1551121 CFR 111.27(d)Equipment - maintain - general
1573621 CFR 111.353Manufacturing operations - written procedures